PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Europe

Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial

Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new prevent...
Continue Reading →
news

PCI Continues to Invest According to Market Demand as Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI), full-service...
Continue Reading →
Australasia

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commer...
Continue Reading →
Europe

PCI Pharma Services Celebrates Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back r...
Continue Reading →
news

CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma

In their phase-2 study of tisagenlecleucel (marketed as KYMRIAH®), to be published on-line Dec. 1, 2018 in the New England Journal of Medicine, an international team ...
Continue Reading →
Europe

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy di...
Continue Reading →
Europe

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke ...
Continue Reading →
Europe

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

Lyon, France, December 4, 2018 – iDD biotech, a French immuno-oncology company with a large pipeline of preclinical and clinical stage monoclonal antibodies, reports ...
Continue Reading →
Europe

Wearable technology could expand electrophysiology market to $2.6bn by 2028, says GlobalData

Following the news that Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation, She...
Continue Reading →
Europe

First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring

Hannover, Germany, December 03, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the f...
Continue Reading →
Quotient